Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Asensus Surgical Inc TRXCD


Primary Symbol: ASXC

Healthcare Medical Devices
Asensus Surgical, Inc. is a medical device company digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery to enable surgeons to deliver outcomes to patients and establish a new standard of surgery. It operates in one business segment, which is the research, development and sale of medical device robotics to improve minimally invasive surgery. It is developing the LUNA Surgical System, a robotic and instrument system as a foundation of its Digital Surgery solution. These systems shall be powered by the Intelligent Surgical Unit to enhance surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, it intends to holistically address the clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. It is also working to incorporate all of this in the LUNA Surgical System.


NYSEAM:ASXC - Post by User

Asensus Surgical Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(11)
•••
Post by tamarion Feb 08, 2021 12:27pm
222 Views
Post# 32501659

Senhance evaluation. - Published online: 05 Feb 2021

Senhance evaluation. - Published online: 05 Feb 2021

Robotic cholecystectomy using Senhance robotic platform versus laparoscopic conventional cholecystectomy: a propensity score analysis

Narimantas E. Samalavicius , Tadas Kaminskas , Zygimantas Zidonis , Vinsas Janusonis , Olegas Deduchovas , Vitalijus Eismontas , show all
Received 04 Oct 2020, Accepted 18 Jan 2021, Accepted author version posted online: 27 Jan 2021, Published online: 05 Feb 2021

https://www.tandfonline.com/doi/full/10.1080/00015458.2021.1881332
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities